2. Introduction
• Hepatitis D, also referred to as hepatitis D virus (HDV) and
classified as Hepatitis delta virus, is a disease caused by a
small circular enveloped RNA virus.
• It is one of five known hepatitis viruses: A, B, C, D, and E.
• HDV is considered to be a sub-viral satellite because it can
propagate only in the presence of the hepatitis B virus (HBV).
• Transmission of HDV can occur either via simultaneous
infection with HBV (co-infection) or superimposed on chronic
hepatitis B or hepatitis B carrier state (super-infection).
4. Magnitude of the problem:
• In the United States, HDV infection is observed more commonly among
patients with a history of intravenous drug use and in persons from the
Mediterranean basin.
• Approximately 15 million people are infected with HDV worldwide. Areas
with the highest prevalence include southern Italy; North Africa; the Middle
East; the Amazon Basin; and the American South Pacific islands of Samoa,
Hauru, and Hiue. China, Japan, Taiwan, and Myanmar (formerly Burma)
have a high prevalence of HBV infection but a low rate of HDV infection.
• HDV infection is more common in adults than in children. However, children
from underdeveloped, HDV-endemic countries are more likely to contract
HDV infection through breaks in the skin, due to the presence of skin
lesions.
5. Epidemiological features:
Infectious agent:
• Hepatitis D virus (HDV) is a virus-like particle consisting of
a coat of hepatitis B virus (HBV) surface antigen and a
unique internal antigen, the delta antigen.
• Reservoirs
Humans
• Host:
Humans
More common in adults than in children.
6. Period of Communicability
• Blood is potentially infectious during all phases of
active hepatitis D infection.
• Peak infectivity probably occurs just prior to onset
of acute illness, when particles containing the
hepatitis D antigen are readily detected in the
blood.
7. Mode of transmission:
This virus is transmitted by the same methods as HBV:
Direct transmission:
• exposure to infected blood and serous body fluids,
• contaminated needles, syringes or blood and plasma
product transfusions.
• Sexual transmission may also occur but is less common
than with hepatitis B.
• mother-to-baby transmission of hepatitis D virus at or
around the time of birth can occur, although this is
uncommon.
8.
9.
10. Sign and Symptoms:
• Fever
• Abdominal pain (especially in the right upper abdomen)
• Muscle and joint pain
• Rashes
14. Prognosis:
Persons with an acute HDV infection usually get
better over 2 to 3 weeks. Liver enzyme levels return
to normal within 16 weeks.
About 10% of those who are infected may develop
long-term (chronic) liver inflammation (hepatitis).
15. Treatment:
• Liver transplantation is indicated in patients with fulminant
liver failure. Patients with evidence of fulminant liver failure
should be immediately transferred to a center capable of
performing a liver transplantation.
• No treatment for hepatitis D virus (HDV) has been approved.
• However, a study of the efficacy of peginterferon alfa-2a
found that treatment with or without adefovir over 48 weeks
resulted in sustained HDV RNA clearance in approximately
one fourth of patients.
• No vaccine is available for HDV, but the HBV vaccination is
effective against HDV.
16. Preventions:
Exclusion of people with hepatitis D from childcare,
preschool, school and work is not necessary.
Hepatitis B vaccination will prevent infection with hepatitis D.
Hepatitis B vaccination is recommended for infants and those
at a higher risk of acquiring hepatitis B infection and/or at
higher risk of severe infection. Vaccination for hepatitis B,
when given to newborn infants, is effective in preventing
hepatitis D (even if the mother has hepatitis D).
Any open sores, cuts or abrasions should be covered with
waterproof dressings
17. Contd…
Practice safer sex – use condoms consistently and correctly.
Injecting drug users should never share injecting equipment.
If required to handle blood or body fluids, the use of standard
precautions will reduce the risk of transmission of hepatitis D
virus.
Infected health care workers must comply with the
requirements of their professional boards.
Educate patient about safe injecting, safe sex and blood and
body fluid precautions.